Free Trial

Tandem Investment Advisors Inc. Increases Stake in Genpact Limited (NYSE:G)

Genpact logo with Computer and Technology background

Tandem Investment Advisors Inc. increased its stake in Genpact Limited (NYSE:G - Free Report) by 6.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,270,143 shares of the business services provider's stock after acquiring an additional 140,228 shares during the quarter. Genpact accounts for approximately 4.0% of Tandem Investment Advisors Inc.'s portfolio, making the stock its 6th largest position. Tandem Investment Advisors Inc. owned approximately 1.29% of Genpact worth $114,370,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of G. Sumitomo Mitsui Trust Group Inc. bought a new position in Genpact in the 1st quarter valued at about $115,807,000. Norges Bank bought a new position in Genpact in the 4th quarter valued at about $90,516,000. Victory Capital Management Inc. lifted its position in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after acquiring an additional 1,511,790 shares in the last quarter. Lord Abbett & CO. LLC bought a new position in Genpact in the 4th quarter valued at about $60,110,000. Finally, Millennium Management LLC lifted its position in Genpact by 829.4% in the 4th quarter. Millennium Management LLC now owns 1,057,389 shares of the business services provider's stock valued at $45,415,000 after acquiring an additional 943,622 shares in the last quarter. Institutional investors own 96.03% of the company's stock.

Insider Buying and Selling at Genpact

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director owned 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 2.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on G. Mizuho lifted their price objective on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Robert W. Baird cut their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $50.00 price objective on shares of Genpact in a report on Monday, June 30th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Genpact has a consensus rating of "Moderate Buy" and an average price target of $50.14.

Check Out Our Latest Research Report on G

Genpact Stock Performance

Shares of NYSE:G traded up $0.93 during midday trading on Friday, reaching $45.92. The company had a trading volume of 1,088,830 shares, compared to its average volume of 1,409,984. The company's 50 day moving average price is $44.31 and its 200 day moving average price is $46.99. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. The stock has a market cap of $8.03 billion, a P/E ratio of 15.67, a P/E/G ratio of 2.00 and a beta of 0.94. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.88% and a return on equity of 22.35%. The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.73 EPS. As a group, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Wednesday, June 18th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend was Wednesday, June 18th. Genpact's dividend payout ratio (DPR) is currently 23.21%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

7 Nuclear Stocks One Announcement Away from Exploding
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines